| Treatment | NW | NE | SW | SE |
|---|---|---|---|---|
| List price | ||||
| Nebulised aztreonam lysine | 392 (3.9%) | 9,330 (93.3%) | 4 (1.1%) | 274 (2.7%) |
| Combinationa | 2,331 (23.3%) | 7,669 (76.7%) | 0 | 0 |
| PAS prices | ||||
| Nebulised aztreonam lysine | 261 (2.6%) | 9,398 (94.0%) | 4 (0.0%) | 337 (3.4%) |
| Combinationa | 1,699 (17.0%) | 8,301 (83.0% | 0 | 0 |
NW, north-west, more expensive and less effective than azithromycin; NE, north-east, more expensive and more effective than azithromycin; SW, south-west, less expensive and less effective than azithromycin; SE, south-east, less expensive and more effective than azithromycin
28 days aztreonam lysine (nebulised) alternating with 28 days tobramycin (nebulised)
From: Appendix K, Health Economics
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.